세계의 LFA(Lateral Flow Assays) 검사 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Lateral Flow Assay Test was estimated to be worth US$ 5892 million in 2024 and is forecast to a readjusted size of US$ 8566 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Global Lateral Flow Assay Test key players include Thermo Fisher, Becton Dickinson, etc. Global top two manufacturers hold a share nearly 25%. North America is the largest market, with a share over 35%, followed by Europe, Asia-Pacific, both have a share about 55 percent. In terms of product, Sandwich Assays is the largest segment, with a share about 65%. And in terms of application, the largest application is Medicine, followed by Environment Testing, Food Safety, etc.

Lateral Flow Test Industry: Technology-Driven Market Innovation and Enterprise Transformation

The lateral flow test industry, driven by technological iteration, is reshaping the testing paradigm in fields such as medical diagnostics, food safety, and environmental monitoring. Its essence lies in enabling rapid qualitative analysis through simple operation, extending its reach from pathogen detection to contaminant screening, and its application scenarios continue to diversify. Currently, the industry's technological path is shifting from traditional test kits to digital and intelligent devices. The widespread adoption of digital/mobile readers has significantly improved testing efficiency and data traceability, while optimizing test kit sensitivity and specificity has become a key differentiator in competitive competition. This technological evolution not only meets the medical field's demand for immediate point-of-care testing (POCT) but also drives food processing companies to upgrade their capabilities for rapid screening of raw material contamination, creating a virtuous cycle of "technology-application-demand."

Market Dynamics and Growth Logic: Increasing Demand and Policy Resonance

Increasing market demand has become the core driver of industry growth. In the medical sector, from tertiary hospitals to primary care clinics, demand for portable testing equipment has surged, driving the simultaneous expansion of the reagent and instrument markets. In the food industry, under comprehensive "farm-to-table" oversight, companies' investment in rapid testing technology has steadily increased. On the policy front, the government, through documents such as the "Action Plan for Metrology to Support the Development of New Industrial Productivity (2025-2030)," has incorporated metrology technology into strategic support areas, encouraging companies to overcome key technological bottlenecks. Meanwhile, capital markets are significantly increasing their interest in the industry. Research reports from leading brokerages indicate that the lateral flow testing sector is expected to see a boost in both performance and valuation by 2025, driven by favorable policies and liquidity. Internationally competitive companies, in particular, are seizing global market share through cross-border mergers and acquisitions and overseas expansion. Business Outlook: Technological Barriers, Deepening Scenario Development, and Ecosystem Building

Leading companies are consolidating their competitive advantages through three main approaches: First, building technological barriers. For example, Danaher and Bio-Rad have built patent moats in reagent sensitivity and device integration through continuous R&D investment. Second, scenario-based solutions are transitioning from single products to "testing + data services." For example, they offer customized testing packages to hospitals or build full-process traceability systems for food companies. Third, global ecosystem collaboration is fostering collaboration. Leading companies are expanding into international markets through mergers and acquisitions or establishing overseas branches. For example, CICC, leveraging its international presence, has rapidly expanded in Hong Kong equity financing, while China Galaxy Securities is increasing its brokerage market share through its Southeast Asian subsidiary. Furthermore, the integration of technologies like blockchain and the Internet of Things is fostering a closed-loop ecosystem of "testing-data-decision-making." For example, combining test data with blockchain ensures transparency and traceability in the food supply chain.

Future Outlook: Industry Restructuring Driven by Innovation

The future of the lateral flow testing industry belongs to those companies that can transform technological breakthroughs into valuable scenarios. With the deep integration of artificial intelligence, big data, and testing technologies, intelligent testing platforms will become standard, and policy support and capital injection will accelerate industry restructuring. Companies need to leverage "technology + scenarios + ecosystem" as their strategic fulcrum, delving deeply into essential sectors like healthcare, food, and the environment. Simultaneously, through global expansion and ecosystem collaboration, they can upgrade from "testing tool providers" to "industry solution leaders." In this process, those who consistently innovate and accurately understand customer needs will seize the initiative in this technology-driven industrial transformation.

This report aims to provide a comprehensive presentation of the global market for Lateral Flow Assay Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Lateral Flow Assay Test by region & country, by Type, and by Application.

The Lateral Flow Assay Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lateral Flow Assay Test.

Market Segmentation

By Company

• Thermo Fisher
• Becton Dickinson
• Abbott
• Hologic, Inc.
• PerkinElmer
• Quidel Corporation
• Biomerieux
• Cytiva (Danaher)
• Qiagen
• Siemens
• BUHLMANN
• IMMY

Segment by Type

• Sandwich Assays
• Competitive Assays

Segment by Application

• Medicine
• Environment Testing
• Food Safety

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Lateral Flow Assay Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Lateral Flow Assay Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Lateral Flow Assay Test in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Lateral Flow Assay Test Product Introduction
• 1.2 Global Lateral Flow Assay Test Market Size Forecast (2020-2031)
• 1.3 Lateral Flow Assay Test Market Trends & Drivers
  • 1.3.1 Lateral Flow Assay Test Industry Trends
  • 1.3.2 Lateral Flow Assay Test Market Drivers & Opportunity
  • 1.3.3 Lateral Flow Assay Test Market Challenges
  • 1.3.4 Lateral Flow Assay Test Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Lateral Flow Assay Test Players Revenue Ranking (2024)
• 2.2 Global Lateral Flow Assay Test Revenue by Company (2020-2025)
• 2.3 Key Companies Lateral Flow Assay Test Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Lateral Flow Assay Test Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Lateral Flow Assay Test
• 2.6 Lateral Flow Assay Test Market Competitive Analysis
  • 2.6.1 Lateral Flow Assay Test Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Lateral Flow Assay Test Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lateral Flow Assay Test as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Sandwich Assays
  • 3.1.2 Competitive Assays
• 3.2 Global Lateral Flow Assay Test Sales Value by Type
  • 3.2.1 Global Lateral Flow Assay Test Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Lateral Flow Assay Test Sales Value, by Type (2020-2031)
  • 3.2.3 Global Lateral Flow Assay Test Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Medicine
  • 4.1.2 Environment Testing
  • 4.1.3 Food Safety
• 4.2 Global Lateral Flow Assay Test Sales Value by Application
  • 4.2.1 Global Lateral Flow Assay Test Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Lateral Flow Assay Test Sales Value, by Application (2020-2031)
  • 4.2.3 Global Lateral Flow Assay Test Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Lateral Flow Assay Test Sales Value by Region
  • 5.1.1 Global Lateral Flow Assay Test Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Lateral Flow Assay Test Sales Value by Region (2020-2025)
  • 5.1.3 Global Lateral Flow Assay Test Sales Value by Region (2026-2031)
  • 5.1.4 Global Lateral Flow Assay Test Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Lateral Flow Assay Test Sales Value, 2020-2031
  • 5.2.2 North America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Lateral Flow Assay Test Sales Value, 2020-2031
  • 5.3.2 Europe Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Lateral Flow Assay Test Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Lateral Flow Assay Test Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Lateral Flow Assay Test Sales Value, 2020-2031
  • 5.5.2 South America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Lateral Flow Assay Test Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Lateral Flow Assay Test Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Lateral Flow Assay Test Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.3.2 United States Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.4.2 Europe Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.5.2 China Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.6.2 Japan Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.7.2 South Korea Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.9.2 India Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Thermo Fisher
  • 7.1.1 Thermo Fisher Profile
  • 7.1.2 Thermo Fisher Main Business
  • 7.1.3 Thermo Fisher Lateral Flow Assay Test Products, Services and Solutions
  • 7.1.4 Thermo Fisher Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Thermo Fisher Recent Developments
• 7.2 Becton Dickinson
  • 7.2.1 Becton Dickinson Profile
  • 7.2.2 Becton Dickinson Main Business
  • 7.2.3 Becton Dickinson Lateral Flow Assay Test Products, Services and Solutions
  • 7.2.4 Becton Dickinson Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Becton Dickinson Recent Developments
• 7.3 Abbott
  • 7.3.1 Abbott Profile
  • 7.3.2 Abbott Main Business
  • 7.3.3 Abbott Lateral Flow Assay Test Products, Services and Solutions
  • 7.3.4 Abbott Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Abbott Recent Developments
• 7.4 Hologic, Inc.
  • 7.4.1 Hologic, Inc. Profile
  • 7.4.2 Hologic, Inc. Main Business
  • 7.4.3 Hologic, Inc. Lateral Flow Assay Test Products, Services and Solutions
  • 7.4.4 Hologic, Inc. Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Hologic, Inc. Recent Developments
• 7.5 PerkinElmer
  • 7.5.1 PerkinElmer Profile
  • 7.5.2 PerkinElmer Main Business
  • 7.5.3 PerkinElmer Lateral Flow Assay Test Products, Services and Solutions
  • 7.5.4 PerkinElmer Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.5.5 PerkinElmer Recent Developments
• 7.6 Quidel Corporation
  • 7.6.1 Quidel Corporation Profile
  • 7.6.2 Quidel Corporation Main Business
  • 7.6.3 Quidel Corporation Lateral Flow Assay Test Products, Services and Solutions
  • 7.6.4 Quidel Corporation Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Quidel Corporation Recent Developments
• 7.7 Biomerieux
  • 7.7.1 Biomerieux Profile
  • 7.7.2 Biomerieux Main Business
  • 7.7.3 Biomerieux Lateral Flow Assay Test Products, Services and Solutions
  • 7.7.4 Biomerieux Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Biomerieux Recent Developments
• 7.8 Cytiva (Danaher)
  • 7.8.1 Cytiva (Danaher) Profile
  • 7.8.2 Cytiva (Danaher) Main Business
  • 7.8.3 Cytiva (Danaher) Lateral Flow Assay Test Products, Services and Solutions
  • 7.8.4 Cytiva (Danaher) Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Cytiva (Danaher) Recent Developments
• 7.9 Qiagen
  • 7.9.1 Qiagen Profile
  • 7.9.2 Qiagen Main Business
  • 7.9.3 Qiagen Lateral Flow Assay Test Products, Services and Solutions
  • 7.9.4 Qiagen Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Qiagen Recent Developments
• 7.10 Siemens
  • 7.10.1 Siemens Profile
  • 7.10.2 Siemens Main Business
  • 7.10.3 Siemens Lateral Flow Assay Test Products, Services and Solutions
  • 7.10.4 Siemens Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Siemens Recent Developments
• 7.11 BUHLMANN
  • 7.11.1 BUHLMANN Profile
  • 7.11.2 BUHLMANN Main Business
  • 7.11.3 BUHLMANN Lateral Flow Assay Test Products, Services and Solutions
  • 7.11.4 BUHLMANN Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.11.5 BUHLMANN Recent Developments
• 7.12 IMMY
  • 7.12.1 IMMY Profile
  • 7.12.2 IMMY Main Business
  • 7.12.3 IMMY Lateral Flow Assay Test Products, Services and Solutions
  • 7.12.4 IMMY Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
  • 7.12.5 IMMY Recent Developments

8 Industry Chain Analysis

• 8.1 Lateral Flow Assay Test Industrial Chain
• 8.2 Lateral Flow Assay Test Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Lateral Flow Assay Test Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Lateral Flow Assay Test Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer